← Leaderboards
James Peter Basilion
Case Western Reserve University
$13,402,848
Attributed
$20,344,188
Total exposure
14
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.5M · FY2006–25$5M$3.8M$2.5M$1.3M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$20,344,188 · 14
By mechanism
R01$19,467,568 · 9
P30$497,408 · 4
R21$379,212 · 1
Top collaborators
- Agata A Exner6 shared
- Xinning Wang6 shared
- Bulent Aydogan4 shared
- David Holt4 shared
- Thomas J. Meade4 shared
- Susann M Brady-Kalnay3 shared
- Michael Kolios1 shared
- Sri Rajasekhar Kothapalli1 shared
Most similar at Case Western Reserve University
Same institution · by research overlap
- Susann M Brady-Kalnay$13,129,878
- Agata A Exner$11,400,255
- Bulent Aydogan$874,158
- Xinning Wang$1,410,982
- Yong Chen$2,615,208
Others in their field
Top investigators on “Tumor”
- David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
- Richard K. Wilson · Washington University$203,917,615
- Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
- Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819
Research focus
TumorMalignant NeoplasmsTechnologyTissuesImageCancer CellDetectionOperative Surgical ProceduresIn VivoClinical TrialsMalignant Neoplasm Of ProstateSuccessNanoparticleDesignCellsTranslatingClinical TranslationDiagnosisRadiation TherapyEngineeringAnimalsRecurrenceCanis FamiliarisLigands
Grant awards (49)
Detection, Radiosensitization and Theranostic Targeting of Metastatic Breast Cancer by PTPmu$668,144
R01 · FY2025 · CA
Fluorescence image guided surgery, adjuvant PDT, and the immune response$577,657
R01 · FY2025 · EB · contact PI
Improved Detection of Prostate Cancer with Nanoparticle-based Ultrasound Contrast Agents Targeted to PSMA$540,920
R01 · FY2025 · EB
Fluorescence-guided resection of breast tumors using a topically-applied molecular probe$173,991
R01 · FY2025 · CA · contact PI
Cancer Imaging$79,209
P30 · FY2025 · CA · contact PI
Fluorescence-guided resection of breast tumors using a topically-applied molecular probe$71,775
R01 · FY2025 · CA · contact PI
Highly selective targeted theranostics for prostate cancers$634,753
R01 · FY2024 · CA · contact PI
Detection, Radiosensitization and Theranostic Targeting of Metastatic Breast Cancer by PTPmu$634,738
R01 · FY2024 · CA
PSMA-targeted AuNPs for MR guided radiotherapy and radiosensitization$631,513
R01 · FY2024 · CA · contact PI
Fluorescence image guided surgery, adjuvant PDT, and the immune response$586,967
R01 · FY2024 · EB · contact PI
Improved Detection of Prostate Cancer with Nanoparticle-based Ultrasound Contrast Agents Targeted to PSMA$536,185
R01 · FY2024 · EB
Fluorescence-guided resection of breast tumors using a topically-applied molecular probe$409,926
R01 · FY2024 · CA · contact PI
Cancer Imaging Research Program$85,834
P30 · FY2024 · CA · contact PI
Detection, Radiosensitization and Theranostic Targeting of Metastatic Breast Cancer by PTPmu$668,144
R01 · FY2023 · CA
Fluorescence-guided resection of breast tumors using a topically-applied molecular probe$652,128
R01 · FY2023 · CA · contact PI
PSMA-targeted AuNPs for MR guided radiotherapy and radiosensitization$651,717
R01 · FY2023 · CA · contact PI
Highly selective targeted theranostics for prostate cancers$641,402
R01 · FY2023 · CA · contact PI
Cancer Imaging Research Program$85,834
P30 · FY2023 · CA · contact PI
PSMA-targeted AuNPs for MR guided radiotherapy and radiosensitization$647,930
R01 · FY2022 · CA · contact PI
Highly selective targeted theranostics for prostate cancers$645,854
R01 · FY2022 · CA · contact PI
Fluorescence-guided resection of breast tumors using a topically-applied molecular probe$523,398
R01 · FY2022 · CA · contact PI
Cancer Imaging Research Program$50,684
P30 · FY2022 · CA · contact PI
PSMA-targeted AuNPs for MR guided radiotherapy and radiosensitization$691,313
R01 · FY2021 · CA · contact PI
Improved Detection of Prostate Cancer with Nanoparticle-based Ultrasound Contrast Agents Targeted to PSMA$631,743
R01 · FY2021 · EB
Highly selective targeted theranostics for prostate cancers$564,002
R01 · FY2021 · CA · contact PI
Fluorescence-guided resection of breast tumors using a topically-applied molecular probe$384,855
R01 · FY2021 · CA · contact PI
Cancer Imaging Research Program$48,651
P30 · FY2021 · CA · contact PI
Improved Detection of Prostate Cancer with Nanoparticle-based Ultrasound Contrast Agents Targeted to PSMA$696,216
R01 · FY2020 · EB
Fluorescence-guided resection of breast tumors using a topically-applied molecular probe$595,998
R01 · FY2020 · CA · contact PI
Cancer Imaging Research Program$46,519
P30 · FY2020 · CA · contact PI
Theranostic gold nanoparticles for imaged-guided radical prostatectomy and PDT ablation$685,730
R01 · FY2019 · EB · contact PI
Improved Detection of Prostate Cancer with Nanoparticle-based Ultrasound Contrast Agents Targeted to PSMA$571,879
R01 · FY2019 · EB
Cancer Imaging Research Program$45,116
P30 · FY2019 · CA · contact PI
Theranostic gold nanoparticles for imaged-guided radical prostatectomy and PDT ablation$664,240
R01 · FY2018 · EB · contact PI
Improved Detection of Prostate Cancer with Nanoparticle-based Ultrasound Contrast Agents Targeted to PSMA$599,741
R01 · FY2018 · EB
Cancer Imaging Research Program$46,304
P30 · FY2018 · CA · contact PI
Cancer Imaging Research Program$9,257
P30 · FY2018 · CA · contact PI
Theranostic gold nanoparticles for imaged-guided radical prostatectomy and PDT ablation$664,240
R01 · FY2017 · EB · contact PI
Theranostic gold nanoparticles for imaged-guided radical prostatectomy and PDT ablation$668,936
R01 · FY2016 · EB · contact PI
Molecular Imaging to Identify Tumor Margins$206,843
R21 · FY2015 · CA · contact PI
Molecular Imaging to Identify Tumor Margins$172,369
R21 · FY2014 · CA · contact PI
Dual-Receptor Targeted Nanoparticles for Photodynamic Therapy of Brain Cancer$179,923
R01 · FY2012 · EB · contact PI
Dual-Receptor Targeted Nanoparticles for Photodynamic Therapy of Brain Cancer$330,676
R01 · FY2011 · EB · contact PI
Imaging of gene expression in glioblastoma$277,775
R01 · FY2010 · CA · contact PI
Imaging of gene expression in glioblastoma$277,775
R01 · FY2009 · CA · contact PI
Imaging of gene expression in glioblastoma$243,763
R01 · FY2009 · CA · contact PI
Imaging of gene expression in glioblastoma$277,775
R01 · FY2008 · CA · contact PI
Imaging of gene expression in glioblastoma$277,775
R01 · FY2007 · CA · contact PI
Imaging of gene expression in glioblastoma$286,071
R01 · FY2006 · CA · contact PI